MedPath

Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury

Not Applicable
Completed
Conditions
Displaced Ankle Fractures
Registration Number
NCT03163017
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to determine if use of new imaging technology termed "3D fluoroscopy" will lead the surgeon to change the position of the fractured bones to a more accurate position.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Skeletally mature
  • Patients with unilateral, acute, displaced ankle fractures with preoperative evidence of syndesmotic disruption or intraoperative evidence of syndesmotic instability following malleolar fixation.
Exclusion Criteria
  • Patients skeletally immature;
  • Patients less than age 18 years and more than age 75;
  • Patients with previous ankle trauma to either ankle;
  • Patients with bilateral ankle injuries;
  • Patients with previous osseous injuries to the tibia or fibula; and
  • Patients with isolated syndesmotic injury and no fracture (i.e. high ankle sprains)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of Participants for Which the Surgeon Changed Reduction of Syndesmotic Reduction Because of Information Provided by 3D FluoroscopyImmediately at the time of 3D Fluoroscopy

Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess syndesmotic reductions.

Secondary Outcome Measures
NameTimeMethod
Alignment as Assessed by the AOFAS Score6 months after 3D Fluoroscopy

The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores

Pain as Assessed by the PROMIS Score6 months after 3D Fluoroscopy

Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures

Number of Participants With Syndesmotic Malreduction as Assessed by a Single Postoperative Bilateral CT Scan1 day after 3D Fluoroscopy

Malreduction will be determined by comparing uninjured ankle to the injured ankle

Function as Assessed by the PROMIS Score6 months after 3D Fluoroscopy

Patient-Reported Outcomes Measurement Information System (PROMIS) patient physical health outcome measures

Number of Participants for Which the Surgeon Changed Reduction of Fibular Fracture Reduction Because of Information Provided by 3D FluoroscopyImmediately at the time of 3D Fluoroscopy

Patients with syndesmotic instability will undergo reduction of the syndesmosis followed by provisional fixation with a clamp or Kirshner wire. The reduction quality will be initially compared to the contralateral ankle mortise and talar-dome lateral radiographs using the technique of Summers (2D Fluoroscopy). After the attending surgeon is satisfied with the reduction quality, 3D fluoroscopy will be used to generate additional images to assess fibular fracture reductions.

Pain as Assessed by the AOFAS Score6 months after 3D Fluoroscopy

The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores

Function as Assessed by the AOFAS Score6 months after 3D Fluoroscopy

The patient outcome variables studied will include American Orthopedic Foot and Ankle Society (AOFAS) scores

Trial Locations

Locations (1)

The University of Texas at Health Science Center at Houston

🇺🇸

Houston, Texas, United States

The University of Texas at Health Science Center at Houston
🇺🇸Houston, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.